ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.69
+0.06 (1.07%)
Aug 7, 2026, 4:00 PM EDT - Market closed

ImageneBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6477472396451
Market Cap Growth
-63.56%63.03%104.11%-75.96%-78.62%-
Enterprise Value
-70.06-55.22221.26-141.54-54.81225.9
Last Close Price
5.696.9019.6823.6431.92150.48
PS Ratio
-96.4413.522.536.1814.56
PB Ratio
0.450.58-0.290.140.662.17
P/TBV Ratio
0.440.25-0.480.661.69
EV/Sales Ratio
--69.0363.22-15.45-3.517.29
EV/EBITDA Ratio
-1.16-1.900.78-
EV/EBIT Ratio
-1.14-1.880.77-
EV/FCF Ratio
-1.15-1.770.73-
Debt / Equity Ratio
-0.01-0.160.040.030.02
Net Debt / Equity Ratio
-0.94-0.990.03-0.97-1.03-1.08
Net Debt / EBITDA Ratio
2.332.790.122.212.166.71
Net Debt / FCF Ratio
2.552.770.192.062.003.63
Asset Turnover
-0.010.030.050.070.15
Quick Ratio
20.7112.050.7012.357.308.54
Current Ratio
21.4712.490.7212.587.448.70
Return on Equity (ROE)
-38.14%-68.91%-43.47%-43.04%-38.76%-21.81%
Return on Assets (ROA)
-38.59%-56.93%-35.59%-41.50%-33.75%-16.40%
Return on Invested Capital (ROIC)
-719.08%--1977.73%-20266.97%--
Return on Capital Employed (ROCE)
-41.06%-68.99%-41.90%-45.90%-38.18%-18.93%
Buyback Yield / Dilution
97.61%0.00%-40.05%-15.33%-29.32%-911.88%
Total Shareholder Return
97.61%0.00%-40.05%-15.33%-29.32%-911.88%
SEC Filings: 10-K · 10-Q